» Articles » PMID: 31041335

Matrix-Associated Autologous Chondrocyte Implantation Is an Effective Treatment at Midterm Follow-up in Adolescents and Young Adults

Overview
Specialty Orthopedics
Date 2019 May 2
PMID 31041335
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autologous chondrocyte implantation (ACI) is an established method for treating cartilage defects in the knee of adult patients. However, less is known about its effectiveness in adolescents.

Hypothesis: Third-generation matrix-associated ACI (MACI) using spheroids (co.don chondrosphere/Spherox) is an effective and safe treatment for articular cartilage defects in adolescents aged 15 to 17 years, with outcomes comparable with those for young adults aged 18 to 34 years.

Study Design: Cohort study; Level of evidence, 3.

Methods: A total of 71 patients (29 adolescents, 42 young adults) who had undergone ACI using spheroids were evaluated retrospectively in this multicenter study. For adolescents, the mean defect size was 4.6 ± 2.4 cm, and the follow-up range was 3.5 to 8.0 years (mean, 63.3 months). For young adults, the mean defect size was 4.7 ± 1.2 cm, and the follow-up range was 3.8 to 4.3 years (mean, 48.4 months). At the follow-up assessment, outcomes were assessed by using validated questionnaires (Knee injury and Osteoarthritis Outcome Score [KOOS], International Knee Documentation Committee [IKDC] subjective knee evaluation form and current health assessment form, and modified Lysholm score), the magnetic resonance observation of cartilage repair tissue (MOCART) score, and if relevant, time to treatment failure. Safety was assessed by the treatment failure rate.

Results: No significant difference between the 2 study groups was found for KOOS, IKDC, or MOCART scores, with all patients achieving high functional values. A significant difference was found in the modified Lysholm score, favoring the young adult group over the adolescent group (22.3 ± 1.9 vs 21.0 ± 2.4, respectively; = .0123). There were no differences between the rates of treatment failure, with 3% in the adolescent group and 5% in the young adult group.

Conclusion: Third-generation MACI using spheroids is a safe and effective treatment for large cartilage defects of the knee in adolescents at midterm follow-up. Outcomes are comparable with those for young adults after ACI.

Citing Articles

Charting a quarter-century of commercial cartilage regeneration products.

Liu X, Guo X, Pei Y, Pei M, Ge Z J Orthop Translat. 2025; 50:354-363.

PMID: 39968336 PMC: 11833628. DOI: 10.1016/j.jot.2024.10.009.


Analysis of Patients Who Undergo Index Arthroscopy With Biopsy but Not Implantation for Staged Chondrocyte Cell Transplantation.

Kemler B, Johnson E, Evert B, Dees A, Giakas A, Hanna A Orthop J Sports Med. 2024; 12(9):23259671241271705.

PMID: 39328884 PMC: 11425744. DOI: 10.1177/23259671241271705.


Favourable clinical outcomes and low revision rate after M-ACI in adolescents with immature cartilage compared to adult controls: Results at 10 years.

Weishorn J, Wiegand J, Koch K, Trefzer R, Renkawitz T, Walker T Knee Surg Sports Traumatol Arthrosc. 2024; 33(1):167-176.

PMID: 39010715 PMC: 11716355. DOI: 10.1002/ksa.12359.


Knee Cartilage Lesion Management-Current Trends in Clinical Practice.

Jarecki J, Wasko M, Widuchowski W, Tomczyk-Warunek A, Wojciak M, Sowa I J Clin Med. 2023; 12(20).

PMID: 37892577 PMC: 10607427. DOI: 10.3390/jcm12206434.


Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage.

Eremeev A, Pikina A, Ruchko Y, Bogomazova A Int J Mol Sci. 2023; 24(19).

PMID: 37833856 PMC: 10572671. DOI: 10.3390/ijms241914408.


References
1.
Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, Lindahl A . Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res. 2000; (374):212-34. DOI: 10.1097/00003086-200005000-00020. View

2.
Paley D . Correction of limb deformities in the 21st century. J Pediatr Orthop. 2000; 20(3):279-81. View

3.
Oeppen R, Connolly S, Bencardino J, Jaramillo D . Acute injury of the articular cartilage and subchondral bone: a common but unrecognized lesion in the immature knee. AJR Am J Roentgenol. 2003; 182(1):111-7. DOI: 10.2214/ajr.182.1.1820111. View

4.
Henderson I, Tuy B, Oakes B . Reoperation after autologous chondrocyte implantation. Indications and findings. J Bone Joint Surg Br. 2004; 86(2):205-11. DOI: 10.1302/0301-620x.86b2.14324. View

5.
Behrens P, Bosch U, Bruns J, Erggelet C, Esenwein S, Gaissmaier C . [Indications and implementation of recommendations of the working group "Tissue Regeneration and Tissue Substitutes" for autologous chondrocyte transplantation (ACT)]. Z Orthop Ihre Grenzgeb. 2004; 142(5):529-39. DOI: 10.1055/s-2004-832353. View